MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Edwards Lifesciences Corporation DSO Ratio 2011-2026 | EW
Annual DSO Ratio Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.2 | 46.3 | 51.5 | 50.1 | 38.3 | 44 | 50.3 | 52.7 | 49.1 | 51.1 | 50.4 | 51.1 | 58.5 | 66.8 | 69.7 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.7 | 38.2 | 51.2 |
Quarterly DSO Ratio Edwards Lifesciences Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.6 | 40.8 | 40.7 | 41.3 | - | 50.3 | 53.2 | 54.5 | - | 54.8 | 51.8 | 42.5 | - | 21.4 | 21.1 | 41.5 | - | 43.2 | 40.7 | 41.3 | 39.4 | 41.2 | 50.8 | 42.8 | 42.2 | 48.1 | 50.7 | 48.5 | 41.1 | 43 | 40.5 | 43.1 | 45.1 | 48.7 | 46.6 | 40.6 | 48.7 | 53.6 | 49.8 | 47.8 | 44.5 | 50.6 | 50.9 | 48.9 | 45.1 | 48.7 | 51.6 | 54.8 | 53.6 | 60.4 | 57.9 | 59.6 | 57.8 | 67.4 | 64.7 | 66.3 | 70.8 | 73.8 | 67.9 | 70.4 | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 73.8 | 21.1 | 49.2 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
50.8 | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 12.51 | 2.21 % | $ 354 M | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 7.93 | 0.51 % | $ 1.19 B | USA |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
104 | $ 4.37 | 4.0 % | $ 164 M |  France |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
26.4 | $ 1.02 | -0.97 % | $ 17.3 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
2.12 | $ 1.93 | -5.61 % | $ 42.6 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.49 | -0.48 % | $ 30.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 17.47 | -1.91 % | $ 410 M | USA |
 |
LENSAR
LNSR
|
38.9 | $ 5.88 | -2.08 % | $ 70.3 M | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 10.74 | -1.92 % | $ 385 M | USA |
 |
Pulmonx Corporation
LUNG
|
50.8 | $ 1.66 | -1.19 % | $ 67.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
53.8 | $ 73.76 | 0.98 % | $ 4.02 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Myomo
MYO
|
35.3 | $ 1.08 | -1.38 % | $ 45.2 M | USA |
 |
MiMedx Group
MDXG
|
57.3 | $ 3.71 | 1.09 % | $ 548 M | USA |
 |
Electromed
ELMD
|
137 | $ 38.38 | -2.32 % | $ 324 M | USA |
 |
Orthofix Medical
OFIX
|
60 | $ 9.45 | -0.42 % | $ 374 M |  Curacao |
 |
Butterfly Network
BFLY
|
88.9 | $ 4.43 | -4.01 % | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
161 | $ 6.82 | -1.09 % | $ 206 M | Canada |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
76.8 | $ 82.08 | -0.46 % | $ 11.1 B | USA |
 |
Insulet Corporation
PODD
|
15.2 | $ 142.92 | 0.19 % | $ 10.1 B | USA |
 |
Sintx Technologies
SINT
|
67 | $ 2.23 | 1.14 % | $ 6.18 M | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 35.78 | 1.02 % | $ 1.11 B | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 42.81 | -0.67 % | $ 1.26 B | USA |
 |
Integer Holdings Corporation
ITGR
|
58.2 | $ 90.22 | 0.21 % | $ 3.13 B | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
TransMedics Group
TMDX
|
54.9 | $ 68.4 | 0.84 % | $ 2.33 B | USA |